Crossmark

Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit

Published Online: 2021-09-01

Authors

Reisinger, Alexander C. https://orcid.org/0000-0002-5773-5695
Niedrist, Tobias

Posch, Florian

Hatzl, Stefan

Hackl, Gerald

Prattes, Juergen https://orcid.org/0000-0001-5751-9311
Schilcher, Gernot

Meißl, Anna-Maria

Raggam, Reinhard B.

Herrmann, Markus

Eller, Philipp
License Information

Text and Data Mining valid from 2021-09-01

Version of Record valid from 2021-09-01
More Information

Article History

Received: 30 May 2021

Accepted: 6 August 2021

First Online: 1 September 2021

Competing interests

: The authors declare no competing interests.

Document is current